SCHEMBL7098284

SCHEMBL7098284

CCCCCN1CC=NC1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 1/20 0.42
MGLL Q99685 6/20 0.41
FAAH O00519 4/20 0.41
PTGS1 P23219 3/20 0.41
PTGS2 P35354 3/20 0.41
ALDH1A1 P00352 3/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
TLR8 Q9NR97 2/20 0.37
TP53 P04637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CYP3A4 P08684 1/20 0.36
G6PD P11413 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KAT2B Q92831 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19996269 0.77
Hydrochloric Acid SCHEMBL11254760 0.77 NPC1 (0.39) GBA1MGLLFAAHPTGS1PTGS2
SCHEMBL9497270 0.73 KDM4E (0.39) ALDH1A1MAPTTLR8SLC9A1
SCHEMBL183802 0.69 TBXAS1 (0.39)
SCHEMBL11303429 0.69 GBA1 (0.42) GBA1MGLLFAAHPTGS1PTGS2
SCHEMBL6779927 0.69 MGLL (0.50) GBA1MGLLFAAHPTGS1PTGS2
SCHEMBL9632622 0.69 GBA1 (0.42) GBA1MGLLFAAHPTGS1PTGS2
SCHEMBL14917573 0.69 MGLL (0.38) GBA1MGLLFAAHPTGS1PTGS2
SCHEMBL4421172 0.69 GBA1 (0.44) GBA1MGLLFAAHPTGS1PTGS2
SCHEMBL8803997 0.69 PLA2G2A (0.47) GBA1MGLLFAAHPTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979083-B1 USE OF 1-AR(ALK)YL-IMIDAZOLIN-2-ONE FOR TREATING ANXIETY AND STRESS CONDITIONS DRESDEN ARZNEIMITTEL (DE) 2003-08-13 EP claimed
EP-0863880-B1 NOVEL 1-AR(ALK)YL-IMIDAZOLIN-2-ONES CONTAINING A DISUBSTITUTED AMINE RADICAL IN THE 4TH POSITION, HAVING AN ANTI-CONVULSIVE EFFECT, AND PROCESS FOR THEIR PRODUCTION ELBION AG (DE) 2003-11-19 EP disclosed
EP-0979083-B1 USE OF 1-AR(ALK)YL-IMIDAZOLIN-2-ONE FOR TREATING ANXIETY AND STRESS CONDITIONS DRESDEN ARZNEIMITTEL (DE) 2003-08-13 EP disclosed
EP-0979083-A2 USE OF 1-AR(ALK)YL-IMIDAZOLIN-2-ONE FOR TREATING ANXIETY AND STRESS CONDITIONS ARZNEIMITTELWERK DRESDEN GMBH (DE) 2000-02-16 EP disclosed
WO-1998052548-A2 USE OF 1-AR(ALK)YL-IMIDAZOLIN-2-ONE FOR TREATING ANXIETY AND STRESS CONDITIONS ARZNEIMITTELWERK DRESDEN GMBH (DE) 1998-11-26 WO disclosed
EP-0863880-A1 NOVEL 1-AR(ALK)YL-IMIDAZOLIN-2-ONES CONTAINING A DISUBSTITUTED AMINE RADICAL IN THE 4TH POSITION, HAVING AN ANTI-CONVULSIVE EFFECT, AND PROCESS FOR THEIR PRODUCTION ARZNEIMITTELWERK DRESDEN GMBH (DE) 1998-09-16 EP disclosed
WO-1997009314-A1 NOVEL 1-AR(ALK)YL-IMIDAZOLIN-2-ONES CONTAINING A DISUBSTITUTED AMINE RADICAL IN THE 4TH POSITION, HAVING AN ANTI-CONVULSIVE EFFECT, AND PROCESS FOR THEIR PRODUCTION ARZNEIMITTELWERK DRESDEN GMBH (DE) 1997-03-13 WO disclosed
US-4777181-A ANTIDIABETIC AGENTS BEIERSDORF AG (DE) 1988-10-11 US disclosed
US-4269990-A CHEMICAL INTERMEDIATES FOR 1-UNSUBSTITUTED-2-(4-INDANYL- OR 5-NAPHTHYLAMINO)-2-IMIDAZOLINE, USEFUL AS DRUGS BASF AKTIENGESELLSCHAFT (DE) 1981-05-26 US disclosed
EP-0011693-A1 N-trifluoromethane-sulfonylaminophenyl-substituted N-heterocycles, their preparation, compositions containing them and their use in regulating plant growth CIBA-GEIGY AG (CH) 1980-06-11 EP disclosed